Hoya (7741) Stock Price, Fundamentals & Analysis

What 7741 does

Hoya (7741) is a Tokyo Stock Exchange–listed stock in the Healthcare sector, specifically the Medical Instruments & Supplies industry. The company designs and manufactures high-tech and medical products for markets in Japan, Asia, the Americas, Europe, and internationally. It operates through two segments: Life Care, and Information and Communications. Life Care covers eyeglasses, contact lenses, medical endoscopes, intraocular lenses, laparoscopic surgical instruments, automatic endoscope cleaning equipment, and prosthetic ceramic fillers and metallic implants for orthopedics, brain surgery, and dentistry. The company also runs Eyecity, a specialty contact lens retailer. On the information technology side, Hoya supplies mask blanks and photomasks for semiconductor manufacturing, glass disks for hard disk drives, and imaging products such as optical glasses, optical lenses, colored glass filters, and UV light resources, as well as photomasks for flat panel displays. Hoya was founded in 1941 and is headquartered in Shinjuku, Japan. It is part of the Nikkei 225 index and operates alongside peers such as Olympus (7733) and Shionogi (4507).

Key numbers explained

• Hoya trades at 23,485 JPY, up 1.49% today. The 52-week range is 19,930 – 30,400, and the stock is 15.5% higher than a year ago.
• The trailing P/E ratio of 31.5 shows how much investors pay per unit of recent earnings; the forward P/E ratio of 34.4 reflects the same idea based on expected future earnings.
• Trailing earnings per share is 744.47 JPY, and the company returns 40% of earnings as dividends, with a dividend yield of 1.26%.
• The ex-dividend date is 30 mar. 2026; buyers on or after that date do not receive the next dividend.
• Revenue over the last twelve months is 983,64 mld. JPY, growing 16,2% year over year, with a profit margin of 27,2% and an operating margin of 32,4%.
• Return on equity of 26,5% indicates how efficiently the company generates profit from shareholders' equity, while the debt-to-equity ratio of 4,4% shows a modest level of debt relative to equity.
• The price-to-book ratio of 7,74 compares the market price to the company's book value per share.

What to watch

• Healthcare demand and government reimbursement policies can affect Hoya's Life Care segment, while semiconductor and display manufacturing cycles influence the Information and Communications side.
• Currency movements, especially the Japanese yen, can impact reported revenue and margins for a Tokyo-listed exporter.
• Regulatory approvals and medical device innovation trends may shape long-term growth in endoscopes, intraocular lenses, and implant products.
• Investors tracking the Tokyo Stock Exchange stocks space may compare Hoya with peers such as Daiichi Sankyō (4568) and M3, Inc. (2413) for broader sector context.
• The next earnings report is scheduled for 30 oct. 2026, which typically prompts updated analyst commentary and price sensitivity.